Last reviewed · How we verify
Live Attenuated Yellow Fever 17D Vaccine
Live Attenuated Yellow Fever 17D Vaccine is a Biologic drug developed by Emory University. It is currently FDA-approved.
At a glance
| Generic name | Live Attenuated Yellow Fever 17D Vaccine |
|---|---|
| Sponsor | Emory University |
| Modality | Biologic |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Durability of Vaccine Responses (PHASE4)
- A Phase 1, First-in-human, Double-blinded, Randomized, Placebo-controlled Trial of a Zika Virus Purified Inactivated Vaccine (ZPIV) With Alum Adjuvant in Healthy Flavivirus-naive and Flavivirus-Primed Subjects. (PHASE1)
- Immune Response to Rotavirus Vaccine After a Supplemental Dose Given at 9 Months of Age With Local EPI Vaccines in Mali (PHASE4)
- Yellow Fever Virus Vaccine and Immune Globulin Study (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Live Attenuated Yellow Fever 17D Vaccine CI brief — competitive landscape report
- Live Attenuated Yellow Fever 17D Vaccine updates RSS · CI watch RSS
- Emory University portfolio CI
Frequently asked questions about Live Attenuated Yellow Fever 17D Vaccine
What is Live Attenuated Yellow Fever 17D Vaccine?
Live Attenuated Yellow Fever 17D Vaccine is a Biologic drug developed by Emory University.
Who makes Live Attenuated Yellow Fever 17D Vaccine?
Live Attenuated Yellow Fever 17D Vaccine is developed and marketed by Emory University (see full Emory University pipeline at /company/emory-university).
What development phase is Live Attenuated Yellow Fever 17D Vaccine in?
Live Attenuated Yellow Fever 17D Vaccine is FDA-approved (marketed).